Development and characterization of xenograft model systems for adenoid cystic carcinoma. - Test2 - elhamkhani - TriplyDB

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

http://www.wikidata.org/entity/Q30410903

about

TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling Adenoid cystic carcinoma: clinical and molecular features.A Phase II study of Dovitinib in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma.An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials.Mutation signature of adenoid cystic carcinoma: evidence for transcriptional and epigenetic reprogramming Interpretation of immunohistochemistry data of tumor should consider microenvironmental factors.Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer.Fatty Acid binding protein 7 is a molecular marker in adenoid cystic carcinoma of the salivary glands: implications for clinical significance.A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets.Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screening Adenoid cystic carcinoma: emerging role of translocations and gene fusions Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.Radiosensitization of adenoid cystic carcinoma with MDM2 inhibition.Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.Clinical and molecular insights into adenoid cystic carcinoma: Neural crest‐like stemness as a target.Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.Clinical and molecular insights into adenoid cystic carcinoma: Neural crest-like stemness as a target.Salivary gland cancer patient-derived xenografts enable characterization of cancer stem cells and new gene fusions associated with tumor progression.

P2860

Q24299955-2C4F2AA2-C526-4988-B93C-5E4974EBED96 Q26781643-C07AD8C4-7E07-48C3-9E4B-977C77209455 Q26996614-0B8E3F0B-F8AC-4E59-AFF7-31DADBCE0D60 Q30252721-9BA412DF-B40A-4DCC-B2A8-5CBDB2B9EB46 Q30276974-42FC4E8B-3A9C-4E38-A86E-0171554E524E Q30277227-925911FF-2D45-4E3B-9CF3-8CF26A71B879 Q30277644-F8D0A377-E221-4642-813A-8A6528EAF055 Q30301145-7959A5C8-E2DD-4279-B618-B489F177ABA0 Q30415512-15E4A374-951F-4944-8CEA-22A10E4F2897 Q30907606-9FDE291E-58F6-437F-BD0C-4A5C9364890C Q34504939-940201AB-F309-466E-B487-C6A2A75CA969 Q35028807-D1EA0ABC-4F88-4A6E-B625-6D26FE9A8B60 Q35149666-9EAFFDBF-F5DF-4644-979D-B835441D69A1 Q36726987-DCBD9221-DCE1-4548-A3A1-CF20BC7CD22E Q36992178-84B4E047-FD87-4953-AC10-3E1DB743797D Q37662396-32D5398B-B160-4CD8-810E-30D1BC8725CC Q38275143-65D055A8-BD13-4204-9F4C-E3E696D36B74 Q38376366-35F823FE-B278-41EB-9D6D-52B2210F53F2 Q38703939-47563AF6-6A4C-43E8-80EE-9E984DA2E442 Q39168179-558C09FF-0CF0-427B-92D9-2AC5BFB0979F Q40202793-3D18DC8E-B21D-4B9D-8262-C46AC31FD709 Q41194627-F9457159-E2C1-42B1-BBAC-076431DE0DE4 Q46831652-E87B412F-5621-40CF-9343-CEB6C87644A3 Q47735648-0494D3A6-BE65-4F61-BAE5-4F8A758F5267 Q47999487-6755B54A-3AC2-48B9-AB98-41D75412D5EC Q52648065-20EAEE06-55EE-4B6E-9C46-E374097FFDC7

P2860

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

http://www.wikidata.org/entity/Q30410903

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

@ast

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

@en

type

label

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

@ast

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

@en

prefLabel

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

@ast

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

@en

P1433

Q30410903-D966D4B9-75D1-45AA-B13C-220C1536C486

P1476

Q30410903-BD4C1FAA-C0E8-4B8A-A6D4-4DD469CCCECB

P2093

Q30410903-11C6965B-C4CC-4B7B-97EE-17CE998729A5

Q30410903-18CE3D83-525D-46D7-AA34-120FFEC56664

Q30410903-51074D49-1B35-4120-9B6F-50CCC8D2EA95

Q30410903-6D8005F5-6272-4EAF-AE7F-816B5BA39A8F

Q30410903-86B77991-0B7C-4786-A344-40C6BC20D785

Q30410903-8BB3BF0E-6314-43F0-B9C5-B32D1B2C5725

Q30410903-B7B08DCF-C643-4B9A-BDC3-794680C19A95

P2860

Q30410903-23D1AE5C-9068-49E5-B88E-0919D3C7B848

Q30410903-24A64FB7-B808-4347-BF23-8C8FFF194848

Q30410903-24CF5F47-8D94-4982-BB08-DE29E0CF497F

Q30410903-66B82266-9164-4A6C-BBA6-9FE86D00A3EF

Q30410903-6BCDFB4D-F812-4590-B14C-AB0AF9AF6797

Q30410903-8332A415-9800-4998-85D5-FBD3A34AEA57

Q30410903-872D0FF5-FEB0-40D9-BEE2-750950EB3DC3

Q30410903-A5F9048C-5C1D-4C3F-B753-F5C68C7B1B53

Q30410903-D7E97558-A4E4-4B20-A80F-81C1F9545E5C

Q30410903-DCF10FF3-AD2A-4548-A6C9-38C0741F3899

P2888

Q30410903-9D4088B3-341C-49A6-B442-BD2C30CB2E2C

P304

Q30410903-39394ADB-8B5E-4D4D-A25B-A42F9CF11F13

P31

Q30410903-89675427-684A-4150-A1F5-42D4352B0A92

P356

Q30410903-8D0A2793-A787-480F-B29D-D7CA4DC537F2

P433

Q30410903-FC1C22CB-C30D-49AB-87FD-2F219CD189FC

P478

Q30410903-6BC3E159-37D2-4F0B-8187-EA3B6C8DC4E1

P50

Q30410903-5BE0A4E8-AA54-49D9-B0A5-88B76F630761

P577

Q30410903-4D64394C-D9BD-4AA5-A09D-C4637EBFEF45

P5875

Q30410903-A0FC7511-ECBE-4E11-AB97-E063205E77DA

P6179

Q30410903-55680F4F-B02A-467E-B72B-09A1B3D5B3EA

P698

Q30410903-716E745F-CB26-4D69-A199-F90F0DD432AB

P921

Q30410903-9B5FE687-1CC7-4908-9DD5-DA1BCC4F9EC3

P932

Q30410903-8E54BD7F-361C-4514-BDA7-75F3A4C59B78

P356

LABINVEST.2011.105

P1433

Laboratory Investigation

P1476

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

@en

P2093

Alexander S Baras

http://www.w3.org/2001/XMLSchema#string

Dawn C Dirks

http://www.w3.org/2001/XMLSchema#string

Hao Fan

http://www.w3.org/2001/XMLSchema#string

Henry F Frierson

http://www.w3.org/2001/XMLSchema#string

Robert J Davidson

http://www.w3.org/2001/XMLSchema#string

Stefani A Mancuso

http://www.w3.org/2001/XMLSchema#string

Wendy L Golden

http://www.w3.org/2001/XMLSchema#string

P2860

Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma

Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2.

Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality.

Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study

Adenoid cystic carcinoma of the paranasal sinuses or nasal cavity: a 40-year review of 35 cases.

MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.

Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials.

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma.

P2888

labinvest.2011.105

P304

1480-1490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.2011.105

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Christopher Moskaluk

P577

2011-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51254116

http://www.w3.org/2001/XMLSchema#string

P6179

1015006388

http://www.w3.org/2001/XMLSchema#string

P698

21709671

http://www.w3.org/2001/XMLSchema#string

P921

P932

4151120

http://www.w3.org/2001/XMLSchema#string